Trademark: 79278882
Word
UMZOON
Status
Registered
Status Code
700
Status Date
Tuesday, August 25, 2020
Serial Number
79278882
Registration Number
6132814
Registration Date
Tuesday, August 25, 2020
Mark Type
4000
Filing Date
Saturday, November 30, 2019
Published for Opposition
Tuesday, June 9, 2020

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; stem cells for pharmaceutical and medical purposes
44 Collection and preservation of blood; collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services

Trademark Events
Jan 3, 2021
Final Decision Transaction Processed By Ib
Dec 15, 2020
Final Disposition Notice Sent To Ib
Dec 15, 2020
Final Disposition Processed
Nov 25, 2020
Final Disposition Notice Created, To Be Sent To Ib
Aug 25, 2020
Registered-Principal Register
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
May 6, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 6, 2020
Teas Change Of Correspondence Received
May 6, 2020
Teas Change Of Domestic Representatives Address
May 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2020
Teas Change Of Owner Address Received
Apr 30, 2020
Approved For Pub - Principal Register
Apr 24, 2020
Teas/Email Correspondence Entered
Apr 24, 2020
Correspondence Received In Law Office
Apr 24, 2020
Teas Response To Office Action Received
Apr 10, 2020
Refusal Processed By Ib
Mar 18, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 18, 2020
Refusal Processed By Mpu
Mar 3, 2020
Application Filing Receipt Mailed
Feb 28, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Feb 27, 2020
Non-Final Action Written
Feb 27, 2020
Assigned To Examiner
Feb 26, 2020
New Application Office Supplied Data Entered In Tram
Feb 21, 2020
Limitation From Original Application Entered
Feb 13, 2020
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24